Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Abmd | Vintage Vibes

3 Stocks to Buy Now That Are Worth Every Penny

Over the past year, the central bank has raised interest rates eight times to control inflation, which is still well above its 2% goal. The recent collapse of the financial system further complicates the Fed’s efforts in its fight against stubborn inflation. Amid this, it could be wise to invest…

StockNews.com

3 Top Pharma Stocks to Buy for the Long Haul

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

StockNews.com

1 Stable Stock to Put on Your Buy List Now

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Stocks to Buy Now and Hold for the Long Term

As the Fed hinted at raising interest rates through 2023, investors are worried about a recession. However, the rate hike aggression is expected to slow down if inflation keeps cooling. Regardless of market conditions, buying and holding fundamentally sound stocks Johnson & Johnson (JNJ), Berry Corporation (BRY), Honda Motor Company…

StockNews.com

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

StockNews.com

3 Stocks to Buy That Could Make You a Millionaire in the Long Term

Yesterday’s retail sales report showed that consumers pulled back on spending last month, raising fears of a recession. Moreover, the Fed signaled to keep raising rates more through the following year. Given an uncertain market backdrop, investors should buy fundamentally sound and dividend-paying stocks Johnson (JNJ), Coca-Cola (KO), and Cardinal…

StockNews.com

The Best Blue-Chip Stock to Buy for 2023 and Beyond

Pharmaceutical giant Johnson & Johnson (JNJ) topped consensus estimates in the last quarter. Shares of this well-established blue-chip company are all set to weather the possible market volatility next year. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Dow Stocks You Can Always Buy and Hold Onto

After the Fed Chair's assurance about the eventual rate hike slowdown, the Dow gained substantially and entered a new bull market. Moreover, the U.S. economy seems resilient enough to withstand any potential growth reduction. Therefore, investors could consider buying fundamentally sound Dow stocks Johnson & Johnson (JNJ) and Cisco Systems…

StockNews.com

4 Stocks That Can Help Fire up Your Portfolio This Winter

Recent data indicates the signs of slowing down inflation. Additionally, the Fed is leaning toward slowing its pace of rate hikes. Amid this, fundamentally strong stocks Johnson & Johnson (JNJ), CVS Health (CVS), Douglas Dynamics (PLOW), and Genie Energy (GNE) might be ideal additions to your portfolio this winter. Continue…

StockNews.com

3 Stocks That Always Thrive While Others Fall

Although October CPI data came in lower than expected, inflation is still hovering at an uncomfortably high level. As the Fed is expected to maintain its hawkish stance to control such high inflation, the economy could witness a recession next year. Hence, it could be wise to invest in defensive…

StockNews.com

1 Stock That's Always a Safe Bet Amid Market Volatility

Leading healthcare company Johnson & Johnson (JNJ) has been able to navigate the volatile market conditions due to the defensive nature of its business and solid fundamentals. Moreover, the company has an impressive history of increasing its dividends. Given JNJ’s robust financials, high profitability, and consistent dividend payouts, we think…

StockNews.com

2 Resilient Stocks to Buy and Hold Through a Recession

The World Bank has warned about a global recession next year. Moreover, although the October inflation report shows signs of cooling price pressures, inflation is still far from the Fed’s target level. Hence, we believe fundamentally solid dividend-paying stocks Johnson & Johnson (JNJ) and McDonald’s Corporation (MCD) could be ideal…

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

4 Stocks That Deserve a Spot in Your Portfolio

While inflation remains a major concern, Goldman Sachs’ top economist still sees the chances of the economy avoiding a recession. However, amid prevailing uncertainties, we think fundamentally strong stocks Johnson & Johnson (JNJ), Volkswagen (VWAGY), Stellantis (STLA), and Core Molding Technologies (CMT) might be worth adding to your portfolio. Continue…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Buy These 4 Stocks Now to Get Richer in 2023

With the Fed approving the fourth consecutive 75-bps interest rate hike earlier this week and slower but surer hikes to follow, the market has begun testing its depth and investors’ patience yet again. However, this provides opportunities to load up on fundamentally sound stocks Johnson & Johnson (JNJ), PepsiCo (PEP),…

Benzinga

Recap: Abiomed Q4 Earnings

Abiomed (NASDAQ:ABMD) reported its Q4 earnings results on Thursday, April 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

A Preview Of Abiomed's Earnings

Abiomed (NASDAQ:ABMD) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Abiomed will report an earnings per share (EPS) of $1.09.

Benzinga

What 4 Analyst Ratings Have To Say About Abiomed

Abiomed (NASDAQ:ABMD) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Abiomed's Return On Capital Employed Insights

According to Benzinga Pro data Abiomed (NASDAQ:ABMD) posted a 19.67% decrease in earnings from Q2. Sales, however, increased by 5.25% over the previous quarter to $261.18 million.

Benzinga

Recap: Abiomed Q3 Earnings

Abiomed (NASDAQ:ABMD) reported its Q3 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Ominous Death Cross Forms On Abiomed's Chart

If history is any guide, there may be trouble ahead for shares of Abiomed (NASDAQ:ABMD). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

People

Kritika SarmahHer

727 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.